Should low‑dose aspirin (81 mg daily) be held in a patient with a subacute subdural hematoma?

Should Baby Aspirin Be Held for Subacute Subdural Hematoma?

Yes, discontinue low-dose aspirin (81 mg) when a subacute subdural hematoma is diagnosed, but the timing of discontinuation depends on whether surgical intervention is planned and how urgently it is needed.

Clinical Decision Algorithm

If Surgery is NOT Planned (Conservative Management):

• Stop aspirin immediately upon diagnosis 1
• Conservative management with aspirin discontinuation alone can lead to complete hematoma resolution in select cases
• Monitor clinically with serial imaging as indicated
• The risk of thromboembolic events during a brief aspirin holiday is extremely low (0.02-0.06 events per person half-year) 2

If Surgery IS Planned:

For Urgent/Emergent Surgery (patient deteriorating):

• Proceed to surgery without delay 3
• Stop aspirin at time of diagnosis but do not wait for washout
• Consider platelet transfusion or desmopressin if available 4, 1
• Recent evidence shows no significant difference in outcomes when operating urgently versus waiting 3

For Semi-Elective Surgery (stable patient):

• Stop aspirin and wait ≤5 days before surgery 4
• No benefit to waiting >5 days versus ≤5 days 4
• This brief pause allows partial platelet recovery while minimizing thromboembolic risk

Evidence Supporting This Recommendation

The most recent high-quality randomized trial (SECA trial, 2025) found that continuing aspirin perioperatively did not reduce recurrence rates but showed a trend toward more complications 2. Importantly, this trial demonstrated that recurrence rates with continuous aspirin were lower than historically reported, suggesting modern surgical techniques may mitigate some bleeding risk.

However, a 2026 European multicenter study provides the strongest evidence for acute hemorrhagic complications: perioperative aspirin continuation was associated with a 21.1% rate of acute postoperative hemorrhage within 48 hours, compared to only 2.4% when aspirin was discontinued (adjusted OR 11.58, p=0.023) 4. This represents a clinically significant and statistically robust difference in early hemorrhagic complications.

The 2019 Italian multicenter study found no correlation between timing of discontinuation and outcomes, supporting that even urgent surgery without aspirin washout is safe 3.

Key Nuances and Caveats

Thromboembolic Risk is Minimal:

• Only 1 thromboembolic event (1.0%) occurred across 104 patients in the European cohort 4
• The SECA trial showed cardiovascular event rates of 0.02-0.06 per person half-year 2
• This low risk supports temporary discontinuation even in patients with cardiovascular indications for aspirin

Subacute vs Chronic Distinction:

• While most studies focus on chronic subdural hematomas, the principles apply to subacute hematomas
• The 2023 ACEP guidelines note that delayed intracranial hemorrhage in aspirin users with mild TBI is rare (4% in elderly) but can occur 5
• One case series documented fatal complications in an elderly patient on aspirin undergoing surgery 1

Common Pitfalls to Avoid:

• Don't delay necessary surgery to wait for complete aspirin washout - outcomes are similar with urgent surgery 3
• Don't continue aspirin perioperatively - this significantly increases acute hemorrhage risk 4
• Don't assume aspirin is safe because the patient is stable - 21% hemorrhage rate with continuation is unacceptable 4
• Don't forget discharge instructions - if managing conservatively, clear return precautions are essential 5

Practical Implementation

1. Stop aspirin immediately when subacute SDH is diagnosed
2. Assess need for surgery based on hematoma size, mass effect, and neurological status
3. If surgery needed urgently (GCS decline, significant mass effect): operate without delay
4. If surgery can wait: hold aspirin for ≤5 days, then proceed
5. If conservative management: continue aspirin hold, monitor clinically and radiographically
6. Resume aspirin postoperatively once hemostasis is confirmed and surgical site is stable (typically 7-14 days post-op, though specific timing should be individualized based on bleeding risk vs thrombotic indication strength)

The evidence strongly supports aspirin discontinuation for subacute subdural hematoma, with the primary decision being surgical timing rather than whether to hold the medication 4, 2, 3.